PACAP-27   Click here for help

GtoPdb Ligand ID: 2257

Synonyms: pituitary adenylate cyclase activating polypeptide-27
Comment: Sequences of human, mouse, rat and sheep PACAP-27 are identical. As is often the case with peptide molecules, representations of the stereochemistry of PACAP-27 may vary across different resources.
Species: Human, Mouse, Rat, Sheep
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
Isomeric SMILES NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N
InChI InChI=1S/C142H224N40O39S/c1-16-75(10)113(179-108(191)66-156-120(201)102(63-109(192)193)173-135(216)104(67-183)176-119(200)88(146)62-84-65-153-70-157-84)139(220)174-101(58-80-28-18-17-19-29-80)133(214)182-114(79(14)186)140(221)175-103(64-110(194)195)132(213)178-106(69-185)136(217)172-100(61-83-39-45-87(189)46-40-83)131(212)177-105(68-184)134(215)164-93(34-27-54-155-142(151)152)126(207)170-98(59-81-35-41-85(187)42-36-81)129(210)163-92(33-26-53-154-141(149)150)124(205)161-89(30-20-23-50-143)122(203)165-94(47-48-107(147)190)127(208)166-95(49-55-222-15)121(202)159-78(13)118(199)180-111(73(6)7)137(218)167-91(32-22-25-52-145)123(204)162-90(31-21-24-51-144)125(206)171-99(60-82-37-43-86(188)44-38-82)130(211)169-97(57-72(4)5)128(209)160-76(11)116(197)158-77(12)117(198)181-112(74(8)9)138(219)168-96(115(148)196)56-71(2)3/h17-19,28-29,35-46,65,70-79,88-106,111-114,183-189H,16,20-27,30-34,47-64,66-69,143-146H2,1-15H3,(H2,147,190)(H2,148,196)(H,153,157)(H,156,201)(H,158,197)(H,159,202)(H,160,209)(H,161,205)(H,162,204)(H,163,210)(H,164,215)(H,165,203)(H,166,208)(H,167,218)(H,168,219)(H,169,211)(H,170,207)(H,171,206)(H,172,217)(H,173,216)(H,174,220)(H,175,221)(H,176,200)(H,177,212)(H,178,213)(H,179,191)(H,180,199)(H,181,198)(H,182,214)(H,192,193)(H,194,195)(H4,149,150,154)(H4,151,152,155)
InChI Key RZGBUJXSKLDAFE-UHFFFAOYSA-N
Natural/Endogenous Targets
Target
PAC1 receptor
VPAC1 receptor
VPAC2 receptor
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
VPAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 8.9 pKi - 4
pKi 8.9 (Ki 1.3x10-9 M) [4]
Description: inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
PAC1 receptor Ligand is endogenous in the given species Rn Agonist Agonist 8.5 – 8.8 pKi - 1
pKi 8.8 (Ki 1.5x10-9 M) [1]
Description: inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor isoform including the hop1 exon
pKi 8.5 (Ki 3x10-9 M) [1]
Description: inhibition of [125I]-[Ac-His1]PACAP-27 binding to membranes from CHO cells stably expressing the rat PAC1 receptor isoform lacking the hip and hop exons
PAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 6.9 – 8.5 pKi - 2
pKi 8.5 (Ki 2.9x10-9 M) [2]
Description: inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the full length receptor (ENST00000304166)
pKi 8.5 (Ki 3.1x10-9 M) [2]
Description: inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363)
pKi 6.9 (Ki 1.29x10-7 M) [2]
Description: inhibition of [125I]-PACAP-27 binding to membranes from HEK293 cells stably expressing the PAC1 very short receptor
PAC1 receptor Ligand is endogenous in the given species Rn Agonist Agonist 10.0 – 10.1 pEC50 - 1
pEC50 10.1 (EC50 8x10-11 M) [1]
Description: stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor isoform lacking the hip and hop exons
pEC50 10.0 (EC50 1x10-10 M) [1]
Description: stimulation of adenylate cyclase in CHO cells stably expressing the rat PAC1 receptor isoform including the hop1 exon
PAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.4 – 10.6 pEC50 - 2-3,6
pEC50 10.6 (EC50 2.6x10-11 M) [3]
Description: cyclic AMP formation in CHO cells stably expressing recombinant receptor
pEC50 9.1 (EC50 8x10-10 M) [2]
Description: stimulation of cyclic AMP formation in HEK293 cells stably expressing the full length receptor (ENST00000304166)
pEC50 9.0 (EC50 1x10-9 M) [2]
Description: stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 short receptor (ENST00000409363)
pEC50 8.7 (EC50 2x10-9 M) [6]
Description: stimulation of cyclic AMP formation in NIH/3T3 cells stably expressing the recombinant receptor
pEC50 8.5 (EC50 3.3x10-9 M) [3]
Description: calcium influx in CHO cells stably expressing recombinant receptor
pEC50 7.4 (EC50 3.7x10-8 M) [2]
Description: stimulation of cyclic AMP formation in HEK293 cells stably expressing the PAC1 very short receptor
VPAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.6 – 9.9 pEC50 - 3,6
pEC50 9.9 (EC50 1.3x10-10 M) [3]
Description: cyclic AMP formation in CHO cells stably expressing recombinant receptor
pEC50 8.2 (EC50 6x10-9 M) [6]
Description: stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
pEC50 7.6 (EC50 2.26x10-8 M) [3]
Description: calcium influx in CHO cells stably expressing recombinant receptor
VPAC2 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.6 – 9.4 pEC50 - 3,6
pEC50 9.4 (EC50 3.8x10-10 M) [3]
Description: cyclic AMP formation in CHO cells stably expressing recombinant receptor
pEC50 8.4 (EC50 4x10-9 M) [6]
Description: stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
pEC50 7.6 (EC50 2.39x10-8 M) [3]
Description: calcium influx in CHO cells stably expressing recombinant receptor
VPAC1 receptor Ligand is endogenous in the given species Rn Agonist Agonist 9.0 pIC50 - 5
pIC50 9.0 (IC50 1x10-9 M) [5]
Description: inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
VPAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.8 – 8.5 pIC50 - 5-6
pIC50 8.5 (IC50 3x10-9 M) [5]
Description: inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
pIC50 7.8 (IC50 1.5x10-8 M) [6]
Description: inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
VPAC2 receptor Ligand is endogenous in the given species Rn Agonist Agonist 8.0 pIC50 - 5
pIC50 8.0 (IC50 1x10-8 M) [5]
Description: inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor
VPAC2 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.6 – 8.0 pIC50 - 5-7
pIC50 8.0 (IC50 1x10-8 M) [5]
Description: inhibition of [125I]Ro25 1553 binding to membranes from CHO cells stably expressing the recombinant receptor
pIC50 7.7 (IC50 2.1x10-8 M) [7]
Description: inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
pIC50 7.6 (IC50 2.5x10-8 M) [6]
Description: inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
PAC1 receptor Ligand is endogenous in the given species Hs Agonist Agonist 7.6 pIC50 - 6
pIC50 7.6 (IC50 2.5x10-8 M) [6]
Description: inhibition of [125I]-PACAP-27 binding to membranes from NIH/3T3 cells stably expressing the recombinant receptor
Additional information and targets (data relate to human unless otherwise stated)
Description Data Reference
Ligand mentioned in the following text fields